Objective The focus of this review is to summarize recent advances on regenerative
technologies (scaffolding matrices, cell/gene therapy and biologic drug delivery) to promote …

Objective: To systematically assess the literature regarding the clinical, histological, and
radiographic outcome of bone morphogenetic proteins (BMP‐2, BMP‐7) …

Objective: The aim of this randomized‐controlled clinical trial was to evaluate the long‐term
outcome of implants placed in bone augmented with a xenogenic bone substitute material …

Bone disease and trauma can sometimes create defects that require more than current
clinical therapies can provide for effective healing. Scaffolds that release bioactive agents …

Statement of problem Recombinant human bone morphogenetic protein 2 (rhBMP-2) has
been introduced to clinical practice because of its osteoinductive capacity. However, the …

Recombinant human bone morphogenetic protein‐2 has been shown to promote bone
formation because of its osteoinductive property. The purpose of this study was to evaluate …

The periodontium is an appropriate target for regeneration, as it cannot restore its function
following disease. Significantly, the periodontium's limited regenerative capacity could be …

Treatment of mandibular osseous defects is a significant clinical challenge. Maintenance of
the height and width of the mandibular ridge is essential for placement of dental implants …

Bone resorption in edentulous regions often results in inadequate ridge for implant
osseointegration. In order to overcome this problem, the use of osteoconductive biomaterials …

Forty years ago Marshal R. Urist discovered a substance in bone matrix that had inductive
properties for the development of bone and cartilage, until date, at least 20 bone …